About

Established in 2015, Biotech CEO Summit is now global. Biotech CEO Summit provides high-value, relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. These candid discussions take place in a secure, confidential setting.

Who Participates

Global Biotech CEO Summit is limited to CEOs focused on leading their organizations through the ever-evolving biotech landscape, transforming individual companies and the industry as a whole.
Non-CEO participants include a select group of industry leaders.

About the Program

The program includes fireside chats, breakouts and group discussions that address a range of global issues key to biotech CEOs and their companies. The Summit format facilitates engagement, discussion and interaction with and between all CEOs. The topics are identified in consultation with the advisory board, and include discussions on strategy (asset selection, collaborations, market approach), financing (public and private), communications to all audiences (shareholders, investors, board of directors, patients, regulatory bodies, and team), human resources (board and team development and management), and lessons learned during make or break situations.

Participant Benefits

An important benefit of participating in the Summit is the development of trusted relationships between CEOs and the select group of other industry thought leaders. The program is designed to ensure all CEOs spend quality time together. Everyone is encouraged to participate in the candid discussions, to share their experiences and to ask questions. All CEOs are invited to suggest topics for discussion. Throughout the Summit, networking sessions, dinners and activities provide opportunities for CEOs to meet one-on-one and build relationships.

Companies Represented By Their CEOs at Past EU and US Summits

4SC AG
Abdera Therapeutics
ABIVAX
Ablynx
Abzena PLC
Achilles Therapeutics
Actimed Therapeutics
Acucela
Adjuvance Technologies
Aelin Therapeutics
Aimmune Therapeutics
Akari Therapeutics
Albireo Pharma
Allegro
AlphaRose Therapeutics
Amplyx Pharmaceuticals
Anake Therapeutics
Anocca
Apaxen
Apexigen
Apogenix AG
Aqilion
Arcturus Therapeutics
Arecor
Arima Genomics
Aristea Therapeutics
ARMO Biosciences
Artelo Biosciences
Artidis
Asher Biotherapeutics
Ashvattha Therapeutics
Aspen Biosciences
Assembly Biosciences
AtG Therapeutics
Atomwise
AUM Biosciences
Aura Biosciences
Autifony Therapeutics
AVEO Oncology
AzurRx BioPharma
BC Platforms
Binx Health
Bioasis Technologies
BioAtla
BioInvent International
bioLytical Laboratories
Biophytis
Blade Therapeutics
BliNK Biomedical SAS
BRAINCURES
Brinter
Cadrenal Therapeutics
Caliber BioSciences
Calithera Biosciences
Calliditas Therapeutics
Cancer Prevention Pharmaceuticals
Cantargia
Cardior Pharmaceuticals
Carmell Therapeutics
CatalYm GmbH
Cellaion
CellFE
Celltheon
ChemoCentryx
Cold Genesys
Conatus Pharmaceuticals
Concert Pharmaceuticals
Context Therapeutics
Crescendo Biologics
CureVac N.V.
Curve Therapeutics
CXL Ophthalmics
Cytovia Therapeutics
Daré Bioscience
DelMar Pharmaceuticals
Dicerna Pharmaceuticals
Drawbridge Health
Earli
Eden BioPharma
Elex Biotech
Eloxx Pharmaceuticals
EOLO Pharma
Epics Therapeutics
Epilepsygtx
e-Therapeutics
Ethicann Pharmaceuticals
Ethris GmbH
Evotec AG
Evox Therapeutics
Exicure
Flux Therapeutics
Function Oncology

G1 Therapeutics B.V.
Gadeta B.V.
Gate Neurosciences
GeNeuro
Genocea
Genome Medical
Glycostem Therapeutics BV
Graybug Vision
Harpoon Therapeutics
hC Bioscience
Headlamp Health
Heptares Therapeutics
Heyman Biotech
Histogenics
Iconic Therapeutics
IGEM Therapeutics
Ileo Science
Immunicum
ImmusanT
IMV
Incysus Therapeutics
Indaptus Therapeutics
Indi Molecular
Infinimmune
InProTher
InteRNA Technologies B.V
Intravacc
Intus Bio
InVivo Biosystems
Iolyx Therapeutics
Jounce Therapeutics
Jubilant Therapeutics
Kaleidoscope.bio
Kezar Life Sciences
Kintara Therapeutics
Kojin Therapeutics
Kubota Pharmaceutical
Kymab
Labcyte
LabGenius
Lantern Pharma
Leading Biosciences
Lucy Therapeutics
Lyric Bio
Lyric Pharmaceuticals
Lysogene
Mateon Therapeutics
Matinas Biopharma Holdings
MatriSys Bioscience
Maverick Therapeutics
MDXHealth
Medicus Pharma
Medincell
Meditope Biosciences
Menlo Therapeutics
Mereo BioPharma Group plc
metaLinear
Microbion
Mikrobiomik Healthcare
Milestone Pharmaceuticals
MiNA Therapeutics
Minoryx Therapeutics
MiroBio
Mithra
Mnemo Tx
Mobius Scientific
MorphoSys AG
Navigen
Naya Biologics
NeRRe Therapeutics
Neuron23
Nexstim
Nkarta Therapeutics
NKILT Therapeutics
Nucleai
Nuclideum
Nurix
NuVox Pharma
Oak Hill Bio
Ocera
Ochre Bio
Oculis
OcuTerra Therapeutics
Oncolab
OncoOne
OncoSpherix
Oppilotech 
Ordaōs Bio
Origami Therapeutics
Orpheris
Orum Therapeutics
Oxford BioMedica
Oxford BioTherapeutics

PACT Pharma
PalisadeBIO
PDC*line Pharma SA
Peptomyc S.L.
Permanence Bio
Personalized Medicine Partners
Perspective Therapeutics
Petra Pharma
PharmAkea
Phoenix Molecular Designs
Precirix
PredxBio
Principia Biopharma
PRISM BioLab
Probiodrug AG
Propeller Bio
Protagonist Therapeutics
PTM Therapeutics
Quell Therapeutics
Qureator
Radical Bio
Recursion Pharmaceuticals
Refuge Biotechnologies
Reglagene
Reneo Pharmaceuticals
ReNeuron
ResVita Bio
Retrophin
Ribbon Biolabs
Ritter Pharmaceuticals
Roswell Biotechnologies
Sahel Oncology
Sangamo Therapeutics
Saphetor
Sapidyne Instruments
Satellos Bioscience
Savonix
Scenic Biotech
Second Genome
Selvita SA
Sensorion
Shield Therapeutics
Sift Biosciences
Sigmoid Pharma
SiSaf
Sorriso Pharmaceuticals
Sosei Heptares
Spectral Medical
Spirovant
Spruce Biosciences
Starpharma
Star Therapeutics
STC Biologics
Step Pharma SAS
Steri-Tek
Strand Therapeutics
Sutro Biopharma
SutroVax
Switch Therapeutics
Symic Bio
Synthetic Genomics
Tallac Therapeutics
TCR² Therapeutics
Tenpoint Therapeutics
TenSixteen Bio
Terray Therapeutics
TesoRx Pharma
TiGenix NV
Tillotts Pharma AG
Toivoa Therapeutics
Tolero Pharmaceuticals
Travere Therapeutics
Trishula Therapeutics
Tubulis
Turning Point
TxCell SA
Unicycive Therapeutics
Vaccitech
Valley Fever Solutions
Valo Therapeutics
Veracyte
ViaCyte
Viewmind
Viewpoint Molecular Targeting
Vir Biotechnology
Vivace Therapeutics
Wave Life Sciences
WinSanTor
Xencor
XOMA

Organizers

Demy-Colton produces highly specialized targeted investor and business development conferences exclusively for the biopharmaceutical and life sciences industry. With a proven track record and deep domain knowledge, we develop programs that add value and routinely exceed the expectations of our participants.

Security Code:
security code
Please enter the security code:

Submit